Helping people live well longer. Klotho Therapeutics, Inc., (KTI) is a privately held biotechnology company developing modified recombinant versions of the human protein Klotho that has shown great potential to delay diseases of aging and improve longevity. Klotho Team has 250+ Years Pharma Experience, 500+ Clinical Trials, including 60+ drug Approvals including numerous Blockbuster Drugs The company builds upon the $200+ million previously invested in Klotho research that demonstrates how Klotho, a naturally occurring protein in humans and animals, can positively impact aging, cognition, kidney function, fibrosis, and cancer. KTI has worldwide patents on Klotho proteins. KTI is well positioned to enter human trials within 12 months focused on its first indication: to slow the progression of kidney failure, which affects up to 40 million patients in the US per year, with over 600,000 currently on dialysis. Kidney disease represents a multi-billion-dollar market opportunity in the U.S. alone.
View Top Employees from Klotho Therapeutics, Inc.Website | http://www.klotho.com |
Revenue | $5 million |
Employees | 2 (0 on RocketReach) |
Founded | 2016 |
Address | 123 Main St, San Diego, California 92121, US |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Drug Discovery, Health Care |
Competitors | Cascade Biotechnology, CohBar, Inc., Columbus Instruments |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Klotho Therapeutics, Inc. employee's phone or email?
The Klotho Therapeutics, Inc. annual revenue was $5 million in 2024.
Klotho Therapeutics, Inc. is based in San Diego, California.
The NAICS codes for Klotho Therapeutics, Inc. are [54171, 54, 541714, 541, 5417].
The SIC codes for Klotho Therapeutics, Inc. are [873, 87].